193 related articles for article (PubMed ID: 15866553)
41. Time-dependent effects of repeated amphetamine treatment on norepinephrine in the hypothalamus and hippocampus assessed with in vivo microdialysis.
Camp DM; DeJonghe DK; Robinson TE
Neuropsychopharmacology; 1997 Sep; 17(3):130-40. PubMed ID: 9272480
[TBL] [Abstract][Full Text] [Related]
42. Chronic ethanol intake and ageing effects on cortical and basal forebrain cholinergic parameters: morphometric and biochemical studies.
Fernandes PA; Ribeiro AM; Pereira RF; Marra HL; Pittella JE
Addict Biol; 2002 Jan; 7(1):29-36. PubMed ID: 11900620
[TBL] [Abstract][Full Text] [Related]
43. D-amphetamine enhances skilled reaching after ischemic cortical lesions in rats.
Adkins DL; Jones TA
Neurosci Lett; 2005 Jun; 380(3):214-8. PubMed ID: 15862888
[TBL] [Abstract][Full Text] [Related]
44. Amphetamine-induced behavioral activation is associated with variable changes in basal ganglia output neurons recorded from awake, behaving rats.
Gulley JM; Reed JL; Kuwajima M; Rebec GV
Brain Res; 2004 Jun; 1012(1-2):108-18. PubMed ID: 15158167
[TBL] [Abstract][Full Text] [Related]
45. An activity indicator of acute withdrawal depends on amphetamine dose in rats.
White W; White IM
Physiol Behav; 2006 Feb; 87(2):368-76. PubMed ID: 16364380
[TBL] [Abstract][Full Text] [Related]
46. Inorganic lead exposure in the rat activates striatal cFOS expression at lower blood levels and inhibits amphetamine-induced cFOS expression at higher blood levels.
Lewis MW; Pitts DK
J Pharmacol Exp Ther; 2004 Aug; 310(2):815-20. PubMed ID: 15111640
[TBL] [Abstract][Full Text] [Related]
47. Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal.
Barrett RJ; Caul WF; Smith RL
Pharmacol Biochem Behav; 2004 Dec; 79(4):761-71. PubMed ID: 15582685
[TBL] [Abstract][Full Text] [Related]
48. Age- and region-dependent alterations in the GABAergic innervation in the brain of rats treated with amphetamine.
Yin HS; Chen CT; Lin TY
Int J Neuropsychopharmacol; 2004 Mar; 7(1):35-48. PubMed ID: 14725721
[TBL] [Abstract][Full Text] [Related]
49. Reduced density of neuropeptide Y neurons in the somatosensory cortex of old male and female rats: relation to cholinergic depletion and recovery after nerve growth factor treatment.
Cardoso A; Paula-Barbosa MM; Lukoyanov NV
Neuroscience; 2006 Feb; 137(3):937-48. PubMed ID: 16325343
[TBL] [Abstract][Full Text] [Related]
50. Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats.
Tait DS; Brown VJ
Behav Brain Res; 2008 Feb; 187(1):100-8. PubMed ID: 17920704
[TBL] [Abstract][Full Text] [Related]
51. Bidirectional modulation of basal forebrain N-methyl-D-aspartate receptor function differentially affects visual attention but not visual discrimination performance.
Turchi J; Sarter M
Neuroscience; 2001; 104(2):407-17. PubMed ID: 11377844
[TBL] [Abstract][Full Text] [Related]
52. Synaptologic and fine structural features distinguishing a subset of basal forebrain cholinergic neurons embedded in the dense intrinsic fiber network of the caudal extended amygdala.
Loopuijt LD; Zahm DS
J Comp Neurol; 2006 Sep; 498(1):93-111. PubMed ID: 16933208
[TBL] [Abstract][Full Text] [Related]
53. Antisense oligodeoxynucleotide-induced suppression of basal forebrain NMDA-NR1 subunits selectively impairs visual attentional performance in rats.
Turchi J; Sarter M
Eur J Neurosci; 2001 Jul; 14(1):103-17. PubMed ID: 11488954
[TBL] [Abstract][Full Text] [Related]
54. Dissociation between long-lasting behavioral sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task.
Stanis JJ; Marquez Avila H; White MD; Gulley JM
Psychopharmacology (Berl); 2008 Sep; 199(4):539-48. PubMed ID: 18473112
[TBL] [Abstract][Full Text] [Related]
55. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
Prieto-Gómez B; Vázquez-Alvarez AM; Martínez-Peña JL; Reyes-Vázquez C; Yang PB; Dafny N
Life Sci; 2005 Jun; 77(6):635-49. PubMed ID: 15921995
[TBL] [Abstract][Full Text] [Related]
56. Involvement of forebrain in parabrachial neuronal activation induced by aversively conditioned taste stimuli in the rat.
Tokita K; Shimura T; Nakamura S; Inoue T; Yamamoto T
Brain Res; 2007 Apr; 1141():188-96. PubMed ID: 17276421
[TBL] [Abstract][Full Text] [Related]
57. Acute increase of the glutamate-glutamine cycling in discrete brain areas after administration of a single dose of amphetamine.
Pereira FC; Rolo MR; Marques E; Mendes VM; Ribeiro CF; Ali SF; Morgadinho T; Macedo TR
Ann N Y Acad Sci; 2008 Oct; 1139():212-21. PubMed ID: 18991867
[TBL] [Abstract][Full Text] [Related]
58. The amphetamine-induced sensitized state as a model of schizophrenia.
Featherstone RE; Kapur S; Fletcher PJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Nov; 31(8):1556-71. PubMed ID: 17884274
[TBL] [Abstract][Full Text] [Related]
59. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection.
Sarter M; Hasselmo ME; Bruno JP; Givens B
Brain Res Brain Res Rev; 2005 Feb; 48(1):98-111. PubMed ID: 15708630
[TBL] [Abstract][Full Text] [Related]
60. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
Tronci E; Simola N; Carta AR; De Luca MA; Morelli M
J Neurochem; 2006 Aug; 98(4):1078-89. PubMed ID: 16771831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
